Valeant Wins Salix Battle After Upped Bid Makes Endo Bow Out
Valeant Pharmaceuticals International Inc. has boosted its bid to buy fellow drugmaker Salix Pharmaceuticals Ltd. by $15 per share, causing Endo Pharmaceuticals Ltd. to withdraw its offer, the companies said Monday...To view the full article, register now.
Already a subscriber? Click here to view full article